Tinoro

Tinoro operates in the biotechnology sector, specializing in the development of non-thermal PCR (Polymerase Chain Reaction) technology. This novel approach utilizes electric fields to alter the pH distribution within a PCR solution, effectively mimicking traditional thermal cycling but at a much faster rate. The technology significantly reduces device costs by eliminating the need for bulky temperature control hardware, making it an order of magnitude cheaper than typical PCR instruments. Additionally, the cost per test is minimized due to the use of simple, single-use consumables.

The low power requirements of Tinoro's technology make it compatible with handheld, battery-operated devices, broadening its application scope. The company's proprietary analytics software platform further enhances user experience by providing advanced data analysis capabilities.

Tinoro primarily serves the medical diagnostics market, targeting healthcare providers and laboratories that require rapid and cost-effective diagnostic solutions. The business model revolves around the sale of both the PCR devices and the consumables required for each test, generating recurring revenue.

Keywords: non-thermal PCR, electric fields, rapid diagnostics, cost-effective, handheld devices, biotechnology, medical diagnostics, single-use consumables, analytics software, low power.